Frontlight ResearchEarly access
Cytomegalovirus infection trials in South Korea
3 of 4 trials · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEvaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.
- Where
- Seoul
- Age
- 1 year to 25 years
- People
- 6
- Run by
- LucasBio
See details and how to joinNCT07685457 - No phaseTaking peopleEvaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegalovirus Retinitis.
- Where
- Seoul
- Age
- 19 years and over
- People
- 5
- Run by
- LucasBio
See details and how to joinNCT07679412 - Phase 1/2Taking peopleEvaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.
- Where
- Seoul
- Age
- 19 years and over
- People
- 27
- Run by
- LucasBio
See details and how to joinNCT07670468